PPAR-GAMMA AGONIST PIOGLITAZONE INFLUENCES PORTOSYSTEMIC COLLATERAL BLOOD FLOW BUT NOT PORTAL PRESSURE

被引：0
|
作者：
Payer, Berit A. [1 ]
Reiberger, Thomas [1 ]
Fuhrmann, Valentin H. [1 ]
Schwabl, Philipp [1 ]
Horvatits, Thomas [1 ]
Hummel, Thomas [1 ]
Jaeger, Bernhard [1 ]
Mitterhauser, Markus [1 ]
Peck-Radosavljevic, Markus [1 ]
机构：
[1] Med Univ Vienna, Vienna, Austria
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：951A / 951A
页数：1
相关论文
共 50 条
  • [1] Influence of PPAR-gamma agonist pioglitazone on portal hypertensive syndrome, angiogenic and proinflammatory markers
    Payer, Berit A.
    Reiberger, Thomas
    Schwabl, Philipp
    Fuhrmann, Valentin
    Horvatits, Thomas
    Hummel, Thomas
    Mitterhauser, Markus
    Angermayr, Bernhard
    Peck-Radosavljevic, Markus
    HEPATOLOGY, 2012, 56 : 743A - 743A
  • [2] PPARγ AGONIST PIOGLITAZONE REDUCES PORTOSYSTEMIC COLLATERAL BLOOD FLOW VIA MODULATION OF ANGIOGENESIS AND INFLAMMATION IN PPVL RATS
    Schwabl, P.
    Payer, B-A.
    Grahovac, J.
    Boucher, Y.
    Klein, S.
    Trebicka, J.
    Angermayer, B.
    Trauner, M.
    Peck-Radosavljevic, M.
    Reiberger, T.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S80 - S81
  • [3] SORAFENIB DECREASES PORTAL PRESSURE, PORTOSYSTEMIC COLLATERAL BLOOD FLOW AND SPLANCHNIC BLOOD FLOW IN RATS WITH PREHEPATIC PORTAL HYPERTENSION
    Reiberger, T.
    Angermayr, B.
    Schwabl, P.
    Rohr-Udilova, N.
    Peck-Radosavljevic, M.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S279 - S279
  • [4] Non-invasive Multimodality Assessment of Vascular Effects of the PPAR-gamma Agonist-Pioglitazone
    Vucic, Esad
    Calcagno, Claudia
    Rudd, James H.
    Dickson, Steve
    Moon, Jae
    Hayashi, Katsumi
    Whitbread, John
    Law, Ronald E.
    Fuster, Valentin
    Fayad, Zahi A.
    CIRCULATION, 2009, 120 (18) : S363 - S363
  • [5] ANTENATAL PPAR-GAMMA AGONIST PIOGLITAZONE STIMULATES FETAL LUNG MATURATION EQUALLY IN MALES AND FEMALES
    Lee, C.
    Sakurai, R.
    Shen, H.
    Rehan, V
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (01) : 121 - 121
  • [6] Pioglitazone, a PPAR-gamma agonist, prevents alcohol-induced fatty liver in rats.
    Tomita, K
    Azuma, T
    Kitamura, N
    Nishimura, T
    Inokuchi, S
    Kato, S
    Ishii, H
    HEPATOLOGY, 2001, 34 (04) : 464A - 464A
  • [7] A double blind randomised placebo controlled trial of the PPAR-gamma agonist pioglitazone in mild asthma
    Anderson, John
    Mortimer, Kevin
    Pang, Linhua
    Smith, Katherine
    Baileyh, Helen
    Knox, Alan
    Harrison, Tim
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [8] The PPAR-gamma agonist, pioglitazone, reverses neuropathic pain behavior in the obese Zucker Diabetic Fatty Rat
    Donahue, Renee Rivas
    Garrett, Colleen
    Taylor, Bradley
    FASEB JOURNAL, 2009, 23
  • [9] The use of HDAC inhibitor valproic acid and PPAR-gamma agonist pioglitazone in the treatment of anaplastic carcinoma of the thyroid
    Noguchi, Hitoshi
    Murakami, Tsukasa
    Yamashita, Hiroto
    Noguchi, Yasushi
    Uchino, Shinya
    Noguchi, Shiro
    ENDOCRINE JOURNAL, 2010, 57 : S450 - S450
  • [10] The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
    Gray, Elizabeth
    Ginty, Mark
    Kemp, Kevin
    Scolding, Neil
    Wilkins, Alastair
    JOURNAL OF NEUROINFLAMMATION, 2012, 9
12345